Abstract
A retrospective, single-center study was performed from September 2012 to June 2017. Thirty-five common femoral arteries (CFAs) were treated with self-expandable nitinol stents. Two thirds of the cases were for critical limb ischemia and one third for claudication. Technical success was 100% without complications. Although the mean follow-up was only ∼2.5 years, the estimated 5-year primary and assisted primary patency rates were 80% and 96%, respectively. Endovascular treatment with self-expandable nitinol stents in CFA lesions had a high technical success rate, few complications, and high long-term patency rates. CFA stent placement might be a suitable therapeutic alternative for selected patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
